pax-101
Generic: suramin·Code: PAX-101
pax-101: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Kuvatris Therapeutics, Inc. (PXMD) | Phase 2 |
FDA Decisions
Frequently asked questions
Who is developing pax-101?
pax-101 is being developed by Kuvatris Therapeutics, Inc..
What is pax-101's latest FDA decision?
The most recent tracked FDA decision for pax-101 is FDA_Meeting for The Company is preparing for an upcoming FDA meeting on PAX-101..
Get deeper analysis on pax-101
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis